IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 50 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $732,800 | +20.5% | 14,822 | +14.5% | 0.02% | +20.0% |
| Q3 2022 | $608,000 | +22.1% | 12,944 | -6.6% | 0.02% | +42.9% |
| Q2 2022 | $498,000 | +23.9% | 13,858 | +2.4% | 0.01% | +75.0% |
| Q1 2022 | $402,000 | -12.6% | 13,534 | +0.4% | 0.01% | -11.1% |
| Q4 2021 | $460,000 | -23.7% | 13,485 | -17.2% | 0.01% | -18.2% |
| Q3 2021 | $603,000 | +30.0% | 16,292 | +23.8% | 0.01% | +37.5% |
| Q2 2021 | $464,000 | -18.7% | 13,162 | -0.4% | 0.01% | -20.0% |
| Q1 2021 | $571,000 | – | 13,211 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |